adct-301
Showing 1 - 3 of 3
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)
Recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- ADCT-301
-
Durham, North CarolinaDuke University Health System
Jan 10, 2022
Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content, Head Neck Cancer Squamous Cell Carcinoma, NSCLC Trial in
Recruiting
- Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
- +12 more
- ADCT-301
- Pembrolizumab
-
Palo Alto, California
- +9 more
Mar 24, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in United States (ADCT-301)
Terminated
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- ADCT-301
-
Atlanta, Georgia
- +10 more
Feb 12, 2020